子类别 期刊論文 [327/330] 圖書 [1/1] 會議論文/會議摘要 [115/179] 邻近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:74(14.51%) 含全文笔数:443(86.86%) 文件下载次数统计 下载大于0次:443(100.00%) 下载大于100次:425(95.94%) 全文下载总次数:177154(3.31%) 最后更新时间: 2024-11-28 16:05 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati... Survival of advanced/recurrent gast... Topiramate suppresses peri-infarct ... A phase 1 study of biweekly nab-pac... Plain language summary of the FOENI... Outcomes of post-immunotherapy dura... Durvalumab or placebo plus gemcitab... Impact of previous S-1 treatment on... Chromatin remodeling-related PRDM1 ...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目301-325 / 510. (共21页) << < 8 9 10 11 12 13 14 15 16 17 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2015-05	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
2015-04-13	Association of dialysis with the risks of cancers	PLoS ONE. 2015 Apr 13;10(4):Article number e0122856.
2015-04	Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide	Hepatology International. 2015 Apr;9(2):258-268.
2015-04	The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition	Journal of Pharmacological Sciences. 2015 Apr;127(4):404-413.
2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
2015-03	Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1	Oncotarget. 2015 Mar;6(9):6684-6707.
2015-01	Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Journal of Clinical Oncology. 2015 Jan;33(3, Suppl. ):234.
2014-12-01	AMACR amplification in myxofibrosarcomas: A mechanism of overexpression that promotes cell proliferation with therapeutic relevance	Clinical Cancer Research. 2014 Dec 01;20(23):6141-6152.
2014-12	Pegylated arginine deiminase (ADI-PEG20) in relapsed/refractory and/or elder Acute Myeloid Leukemia: The preliminary result of phase II trial	Blood. 2014 Dec;124(21):984.
2014-11-30	MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors	Oncotarget. 2014 Nov 30;5(22):11723-11736.
2014-11	Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance	Oncotarget. 2014 Nov 30;5(22):11428-11441.
2014-10-18	AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: A driver of cell proliferation indicating adverse prognosis	Oncotarget. 2014 Oct 18;5(22):11551-11566.
2014-10-10	Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma	Blood Cancer Journal. 2014 Oct 10;4:Article number eXX.
2014-10	Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922	Clinical and Experimental Pharmacology and Physiology. 2014 Oct;41(10):830-837.
2014-10	Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4217.
2014-09	High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells	European Journal of Pharmacology. 2014 Sep;738:332-341.
2014-09	Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus	Clinical Colorectal Cancer. 2014 Sep;13(3):145-155.
2014-07-02	Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib the EVOLVE-1 randomized clinical trial	JAMA. 2014 Jul 2;312(1):57-67.
2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	Oncology. 2014 Jul;87(2):104-113.
2014-06-20	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity	Blood Cancer Journal. 2014 Jun 20;4:Article number e220.
2014-05	Using chinese herbal medicine containing mu-tong is associated with upper urinary tract cancer in patient with end-stage renal disease	Nephrology, Dialysis, Transplantation. 2014 May;29(Suppl. 3):iii65-iii67.
2014-05	Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148.
2014-05	Association of helicobacter pylori CagA translocation with the expression of CagA-signaling transduction molecules in gastric mucosa-associated lymphoid tissue lymphoma	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):8571.
2014-05	High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.
2014-05	A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):2617.

显示项目301-325 / 510. (共21页) << < 8 9 10 11 12 13 14 15 16 17 > >> 每页显示[10|25|50]项目